Psychostimulants in the treatment of adults with psychosis and attention deficit disorder.
Whether conceptualized as comorbid ADD with psychosis or as a distinct diagnostic entity--ADD psychosis--patients with features of both ADD and psychosis benefit from treatment with psychostimulants. It is hypothesized that psychostimulants have their therapeutic effect via amelioration of frontal lobe dysfunction.
Opler
L A
LA
Department of Psychiatry, Columbia University College of Physicians and Surgeons, and Research Division for the New York State Office of Mental Health, New York, New York 10032, USA. lao1@columbia.edu
Frank
D M
DM
Ramirez
P M
PM
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000627:therapeutic use*; D005625:Frontal Lobe / Q000503:physiopathology; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000503:physiopathology
D000697:Central Nervous System Stimulants